CHROMOPHOBE RENAL CELL CARCINOMA
Clinical trials for CHROMOPHOBE RENAL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new CHROMOPHOBE RENAL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for CHROMOPHOBE RENAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Triple-Drug attack shows promise for rare bladder and kidney cancers
Disease control Recruiting nowThis study tests a combination of three drugs—cabozantinib, nivolumab, and ipilimumab—in people with rare genitourinary cancers that have spread. The goal is to see if this mix can shrink tumors or stop them from growing. About 314 adults with these rare cancers will take part. T…
Matched conditions: CHROMOPHOBE RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 02:06 UTC
-
New drug targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis early-stage trial tests a new drug, NN3201, designed to attack cancer cells that have a specific marker called c-Kit. The study includes people with advanced or spreading cancers like gastrointestinal stromal tumors (GIST), small-cell lung cancer, and others. The main goal i…
Matched conditions: CHROMOPHOBE RENAL CELL CARCINOMA
Phase: PHASE1 • Sponsor: Novelty Nobility, Inc. • Aim: Disease control
Last updated May 04, 2026 16:25 UTC
-
Scientists track Cancer's food choices in real time
Knowledge-focused Recruiting nowThis study looks at how kidney and bladder cancers use nutrients like sugar and fat to grow. About 600 adults having surgery or a biopsy will receive a special nutrient tracer through an IV. Blood and tissue samples are then analyzed to see how the cancer uses these fuels. Partic…
Matched conditions: CHROMOPHOBE RENAL CELL CARCINOMA
Phase: NA • Sponsor: University of Texas Southwestern Medical Center • Aim: Knowledge-focused
Last updated May 14, 2026 12:02 UTC